Publications by authors named "David Christ"

Claim this Profile
T
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
Trudy H Grossman, Michael S Anderson, David Christ, Melanie Gooldy, Lisa N Henning

Antimicrob Agents Chemother· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859).
Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, Lara K Leister, Minghua Gu, David D Christ

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations.
Kan He, Mingxin Qian, Harvey Wong, Stephen A Bai, Bing He, David D Christ

J Pharm Sci· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, Rajan Anand, Rui-Qin Liu, David D Christ

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.
Zhonghui Lu, Gregory R Ott, Rajan Anand, Rui-Qin Liu, Maryanne B Covington, David D Christ

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, Maryanne B Covington, Mingxin Qian, David D Christ

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors.
James J-W Duan, Lihua Chen, Zhonghui Lu, Chu-Biao Xue, Rui-Qin Liu, David D Christ

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).
Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, Rui-Qin Liu, Maryanne B Covington, David D Christ

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey.
J Scott Daniels, Robert Espina, Kevin Cao, Haodan Yuan, Jianrong Lin, David Christ

Chem Res Toxicol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humans.
Mingxin Qian, Stephen A Bai, Bernice Brogdon, Jing-Tao Wu, Rui-Qin Liu, David D Christ

Drug Metab Dispos· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.
James R Pruitt, Douglas G Batt, Dean A Wacker, Lori L Bostrom, Shon K Booker, David D Christ

Bioorg Med Chem Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.
Xiao-Tao Chen, Bahman Ghavimi, Ronald L Corbett, Chu-Biao Xue, Rui-Qin Liu, David D Christ

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.
Harvey Wong, Scott J Grossman, Stephen A Bai, Sharon Diamond, Matthew R Wright, David D Christ

Drug Metab Dispos· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
Robert J Cherney, Ruowei Mo, Dayton T Meyer, Karl D Hardman, Rui-Qin Liu, David D Christ

J Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.
Chu-Biao Xue, Xiaohua He, John Roderick, Ronald L Corbett, James J-W Duan, David D Christ

Bioorg Med Chem Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
Robert J Cherney, James J-W Duan, Matthew E Voss, Lihua Chen, Li Wang, David D Christ

J Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective aggrecanase inhibitors containing cyclic P1 substituents.
Robert J Cherney, Ruowei Mo, Dayton T Meyer, Li Wang, Wenqing Yao, David D Christ

Bioorg Med Chem Lett· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.
Mingxin Qian, Wanda West, Jing-Tao Wu, Bing Lu, David D Christ

Pharm Res· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiography.
Eric G Solon, Suresh K Balani, Gang Luo, Tian J Yang, Paula J Haines, David D Christ

Drug Metab Dispos· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.
James J-W Duan, Lihua Chen, Zelda R Wasserman, Zhonghui Lu, Rui-Qin Liu, David D Christ

J Med Chem· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent P1' biphenylmethyl substituted aggrecanase inhibitors.
Wenqing Yao, Michael Chao, Zelda R Wasserman, Rui Qin Liu, Maryanne B Covington, David Christ

Bioorg Med Chem Lett· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis